Eckert BJ - Search Results

1

International development of the patient-reported outcome indices for multiple sclerosis (PRIMUS).

McKenna SP, Doward LC, Twiss J, Hagell P, Oprandi NC, Fisk J, Grand'Maison F, Bhan V, Arbizu T, Brassat D, Kohlmann T, Meads DM, Eckert BJ. McKenna SP, et al. Among authors: eckert bj. Value Health. 2010 Dec;13(8):946-51. doi: 10.1111/j.1524-4733.2010.00767.x. Value Health. 2010. PMID: 20667058 Free article.

2

Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS).

Twiss J, Doward LC, McKenna SP, Eckert B. Twiss J, et al. Health Qual Life Outcomes. 2010 Oct 11;8:117. doi: 10.1186/1477-7525-8-117. Health Qual Life Outcomes. 2010. PMID: 20937112 Free PMC article. Clinical Trial.

3

International development of the Unidimensional Fatigue Impact Scale (U-FIS).

Doward LC, Meads DM, Fisk J, Twiss J, Hagell P, Oprandi NC, Grand'Maison F, Bhan V, Arbizu T, Kohlmann T, Brassat D, Eckert BJ, McKenna SP. Doward LC, et al. Among authors: eckert bj. Value Health. 2010 Jun-Jul;13(4):463-8. doi: 10.1111/j.1524-4733.2010.00706.x. Epub 2010 Mar 11. Value Health. 2010. PMID: 20230543 Free article.

4

The development of patient-reported outcome indices for multiple sclerosis (PRIMUS).

Doward LC, McKenna SP, Meads DM, Twiss J, Eckert BJ. Doward LC, et al. Among authors: eckert bj. Mult Scler. 2009 Sep;15(9):1092-102. doi: 10.1177/1352458509106513. Epub 2009 Jun 25. Mult Scler. 2009. PMID: 19556315

5

The development and validation of the Unidimensional Fatigue Impact Scale (U-FIS).

Meads DM, Doward LC, McKenna SP, Fisk J, Twiss J, Eckert B. Meads DM, et al. Mult Scler. 2009 Oct;15(10):1228-38. doi: 10.1177/1352458509106714. Epub 2009 Jun 25. Mult Scler. 2009. PMID: 19556314

6

Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study.

Montalban X, Comi G, O'Connor P, Gold S, de Vera A, Eckert B, Kappos L. Montalban X, et al. Mult Scler. 2011 Nov;17(11):1341-50. doi: 10.1177/1352458511411061. Epub 2011 Jul 4. Mult Scler. 2011. PMID: 21727148 Clinical Trial.

7

Annualized relapse rate of first-line treatments for multiple sclerosis: a meta-analysis, including indirect comparisons versus fingolimod.

Roskell NS, Zimovetz EA, Rycroft CE, Eckert BJ, Tyas DA. Roskell NS, et al. Among authors: eckert bj. Curr Med Res Opin. 2012 May;28(5):767-80. doi: 10.1185/03007995.2012.681637. Epub 2012 Apr 24. Curr Med Res Opin. 2012. PMID: 22462530

8

Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries.

Karampampa K, Gustavsson A, Miltenburger C, Eckert B. Karampampa K, et al. Mult Scler. 2012 Jun;18(2 Suppl):7-15. doi: 10.1177/1352458512441566. Mult Scler. 2012. PMID: 22623122

9

Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS.

Cohen JA, Barkhof F, Comi G, Izquierdo G, Khatri B, Montalban X, Pelletier J, Eckert B, Häring DA, Francis G. Cohen JA, et al. J Neurol. 2013 Aug;260(8):2023-32. doi: 10.1007/s00415-013-6932-0. Epub 2013 Apr 30. J Neurol. 2013. PMID: 23632946 Free PMC article. Clinical Trial.

10

Estimating time to disease progression comparing transition models and survival methods--an analysis of multiple sclerosis data.

Mandel M, Mercier F, Eckert B, Chin P, Betensky RA. Mandel M, et al. Biometrics. 2013 Mar;69(1):225-34. doi: 10.1111/biom.12002. Epub 2013 Feb 14. Biometrics. 2013. PMID: 23410536 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters